Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
555 - Can we provide a link from our disease state page on our local website to our global disease state page containing information about the same topic? If a disclaimer pops up prior to the user leaving the Canadian website and viewing content on that disease state global page, are we able to do this?
-
To answer this question, there are a few important details which would need to be considered. Who is the intended regulatory audience, are the sites gated, is the disease information on a product branded site (i.e. are we creating a link between branded and unbranded content). For example, if we assume that the question relates to linking disease information on a product branded HCP gated site to disease information on the global corporate site, the answer is ‘no’. Per the PAAB code, you may link to a corporate global site only by linking to the homepage. An important exception to the ability to link to the global (or local) corporate website homepage follows: based on direction from Health Canada the product branded pre-gate portion of a prescription drug website must not contain a hyperlink to a corporate website containing product monographs. The link between the two may exceed the restrictions set out in Section C.01.044 of the Food & Drug Regulations.
